Acerus Pharmaceuticals Corporation

DB:3TP0 Rapporto sulle azioni

Cap. di mercato: €2.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Acerus Pharmaceuticals Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Ed Gudaitis

Amministratore delegato

US$807.1k

Compenso totale

Percentuale dello stipendio del CEO24.7%
Mandato del CEO4.8yrs
Proprietà del CEO1.0%
Durata media del management3.8yrs
Durata media del Consiglio di amministrazione6yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Ed Gudaitis rispetto agli utili di Acerus Pharmaceuticals?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2022n/an/a

-US$28m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021US$807kUS$199k

-US$34m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$664kUS$177k

-US$24m

Sep 30 2020n/an/a

-US$21m

Jun 30 2020n/an/a

-US$19m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$190kUS$181k

-US$16m

Sep 30 2019n/an/a

-US$17m

Jun 30 2019n/an/a

-US$16m

Mar 31 2019n/an/a

-US$19m

Dec 31 2018US$394kUS$185k

-US$19m

Compensazione vs Mercato: Ed's total compensation ($USD807.09K) is above average for companies of similar size in the German market ($USD431.61K).

Compensazione vs guadagni: Ed's compensation has increased whilst the company is unprofitable.

AMMINISTRATORE DELEGATO

Ed Gudaitis

4.8yrs

Mandato

US$807,086

Compensazione

Mr. Edward Gudaitis, also known as Ed, is President, Director and Chief Executive Officer at Acerus Pharmaceuticals Corp. since May 01, 2018. He is a Director for BioteCanada. Mr. Gudaitis has spent many y...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Edward Gudaitis
President4.8yrsUS$807.09k1.03%
$ 27.0k
Gavin Damstra
Senior Vice President of International Commercial3.8yrsUS$411.98kNessun dato
Christopher Sorli
Chief Medical Officer2.7yrsUS$452.01kNessun dato
Naveed Manzoor
Interim Chief Financial Officerless than a yearNessun datoNessun dato
Chris Witty
Investor Relationsno dataNessun datoNessun dato
Philippe Savard
Senior VP6.7yrsUS$287.97k0.0046%
$ 121.7
Hubert Czerwinski
President of Acerus Pharmaceuticals SRLno dataUS$306.94kNessun dato

3.8yrs

Durata media

Gestione esperta: 3TP0's management team is considered experienced (3.8 years average tenure).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Edward Gudaitis
President4.8yrsUS$807.09k1.03%
$ 27.0k
Samuel Herschkowitz
Vice Chairmanless than a yearNessun dato0.032%
$ 850.5
Ian Ihnatowycz
Chairman of the Board9.5yrsUS$46.15kNessun dato
Stephen Gregory
Independent Director11.7yrsUS$38.12kNessun dato
Borys Chabursky
Lead Independent Director7.3yrsUS$32.11k0.032%
$ 829.2
Geoffrey Cotton
Independent Director2.8yrsUS$44.01kNessun dato

6.0yrs

Durata media

69yo

Età media

Consiglio di amministrazione esperto: 3TP0's board of directors are considered experienced (6 years average tenure).